Utrecht, Netherlands

Genmab B.v.

Calculating rank
USPTO Granted Patents = 10


Trademarks = 2

Forward Citations = 29

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Janine Schuurman (8 out of 60 patents)

silverMedal Frank Beurskens (6 out of 16 patents)

bronzeMedal Paul Parren (6 out of 137 patents)

4.  Rob N De Jong (5 out of 18 patents)

5.  Kristin Strumane (5 out of 5 patents)

6.  Aran Frank Labrijn (4 out of 38 patents)

7.  Marije Overdijk (3 out of 10 patents)

8.  Simone Oostindie (2 out of 9 patents)

9.  Esther Breij (2 out of 14 patents)

10.  Claudine Brigitte Fernande Vermot-Desroches (2 out of 2 patents)

11.  Olivier Frédéric Subiger (2 out of 2 patents)

12.  Laurence Françoise Jeanne-Marie Bourdin (2 out of 2 patents)

13.  Rik Rademaker (1 out of 32 patents)

14.  Arjen Vlug (1 out of 1 patent)

15.  Sandra Verploegen (1 out of 10 patents)


10 patents:

Company Overview
Genmab B.V. is a biotechnology company based in Utrecht, Netherlands, specializing in the development of differentiated antibody therapeutics for the treatment of cancer. The company focuses on innovative research and technology in the field of immuno-oncology, leveraging its proprietary antibody platforms to create novel therapies. Genmab collaborates with various pharmaceutical partners to advance its pipeline, aiming to improve patient outcomes through targeted and effective treatment options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

10 Patents

#14 in Utrecht

#620 in Netherlands

#56,291 in the World

Utrecht, NL
Utrecht, Netherlands
Forward Citations = 29

20 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genmab B.v.. Retrieved from https://idiyas.com/company/genmab-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…